{"schema_version":"secwatch.filing_event.v1","accession":"0001566469-23-000024","form_type":"8-K","ticker":null,"cik":"0001566469","company_name":"NantHealth, Inc.","filed_at":"2023-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.432107+00:00","generated_at":"2026-06-15T13:14:50.857122+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"NantHealth receives Nasdaq delisting notice for failure to meet public float requirement","bullets":["Received Nasdaq notice on May 2, 2023 that common stock will be suspended on May 11, 2023 due to non-compliance with $15M public float requirement.","Company intends to request a hearing by May 9, 2023, which will stay suspension pending Nasdaq hearing process.","Previously disclosed deficiency from October 31, 2022; compliance period ended May 1, 2023.","Stock continues to trade on Nasdaq Global Select Market under symbol NH during the appeal process."],"urls":{"canonical":"https://secwatch.observer/filing/0001566469-23-000024","json":"https://secwatch.observer/filing/0001566469-23-000024.json","markdown":"https://secwatch.observer/filing/0001566469-23-000024.md","text":"https://secwatch.observer/filing/0001566469-23-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1566469/000156646923000024/0001566469-23-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1566469/000156646923000024/nh-20230502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T13:14:50.857122+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b3340de1ad7d298308c22486a5dc20423fdde098","claim":"NantHealth, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5810(c)(3)(A)).","evidence_excerpt":"May 2, 2023, the Company received written notice (the “Notice”) from Nasdaq stating that the Company has not complied with the Public Float Requirement prior to the expiration of the Compliance Period. The Notice indicated that Company’s common stock would be suspended from trading on Nasdaq on May 11, 2023. The Company may appeal the Staff’s determination to a Hearings Panel (the “Panel”), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series, by requesting a hearing before the Panel by 4:00 p.m. Eastern Time on May 9, 2023. The Company intends to timely request a hearin","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1566469/000156646923000024/0001566469-23-000024-index.htm","confidence":0.99,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5450(b)(2)(C), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}